77 results on '"Knight, Richard J"'
Search Results
2. mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipients
3. P8.130: Assessing Patient-Level Predictors of Obesity for Kidney Patients Referred for Pretransplant Evaluation
4. Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External Validation
5. Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients
6. Risk Factors Associated With an Impaired Antibody Response in Kidney Transplant Recipients Following 2 Doses of the SARS-CoV-2 mRNA Vaccine
7. Neurogenic Orthostatic Hypotension: a Common Complication of Successful Pancreas Transplantation
8. Long-Term Follow-Up of Renal Transplant Recipients Treated With IVIG for De Novo Donor-Specific Antibodies
9. Persistent Immunogenicity of the mRNA COVID-19 Vaccine in Patients Vaccinated Before Kidney Transplant
10. Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration
11. LONG-TERM OUTCOMES OF RENAL TRANSPLANT RECIPIENTS TREATED WITH IVIG FOR DE NOVO DONOR SPECIFIC ANTIBODIES
12. Delayed Implantation of Pumped Kidneys Decreases Renal Allograft Futility in Combined Liver–Kidney Transplantation
13. Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti‐thymocyte globulin vs basiliximab
14. Weight Gain After Simultaneous Kidney and Pancreas Transplantation
15. Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center
16. Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial
17. Cross-sectional evaluation of the relationship between vitamin D status and supplement use across levels of kidney function in adults
18. Unexplained fever after pancreas transplantation
19. Short- and midterm results for internal jugular vein extension for short right renal vein kidney transplant
20. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia
21. Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction
22. BK virus as a mediator of graft dysfunction following kidney transplantation
23. Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation
24. The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes
25. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
26. Intermediate-Term Outcomes of Dual Adult versus Single-Kidney Transplantation: Evolution of a Surgical Technique
27. Barriers to Preemptive Renal Transplantation
28. Intermediate-Term Graft Loss After Renal Transplantation is Associated With Both Donor-Specific Antibody and Acute Rejection
29. Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
30. A Surgeons’ Guide to Renal Transplant Immunopathology, Immunology, and Immunosuppression
31. Effects of Rituximab on the Development of Viral and Fungal Infections in Renal Transplant Recipients
32. Screening for BK Viremia Reduces But Does Not Eliminate the Risk of BK Nephropathy
33. Cross-sectional and Case-Control Analyses of the Association of Kidney Function Staging With Adverse Postoperative Outcomes in General and Vascular Surgery
34. Screening for BK Viremia Reduces But Does Not Eliminate the Risk of BK Nephropathy
35. Comparison of laparoendoscopic single site (LESS) and conventional laparoscopic donor nephrectomy at a single institution
36. Treatment of Acute Tacrolimus Toxicity with Phenytoin in Solid Organ Transplant Recipients
37. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation
38. Increased mortality of solid organ transplant recipients with H1N1 infection: a single center experience
39. Effect of Immunosuppression for First Kidney or Kidney/Pancreas Transplant on Sensitization at the Time of Second Transplant
40. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age
41. The role of mTOR inhibition in renal transplant immune suppression
42. Continuous Glucose Monitoring in Subjects After Simultaneous Pancreas-Kidney and Kidney-Alone Transplantation
43. Comparing an Early Corticosteroid/Late Calcineurin-Free Immunosuppression Protocol to a Sirolimus-, Cyclosporine A-, and Prednisone-Based Regimen for Pancreas-Kidney Transplantation
44. Considerations in sirolimus use in the early and late post-transplant periods
45. Risk factors for impaired wound healing in sirolimus‐treated renal transplant recipients
46. A 90-nm CMOS Low-Power GSM/EDGE Multimedia-Enhanced Baseband Processor With 380-MHz ARM926 Core and Mixed-Signal Extensions
47. Long‐term outcomes of single paediatric vs. ideal adult renal allograft transplants in adult recipients
48. Pancreas Transplantation Utilizing Thymoglobulin, Sirolimus, and Cyclosporine
49. Nocturnal haemodialysis: An Australian cost comparison with conventional satellite haemodialysis (Review Article)
50. Low Incidence of Malignancy among Sirolimus/Cyclosporine-Treated Renal Transplant Recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.